Table 4 Relation of adherence level to HEP among exercise group with regard to clinical characteristics and outcome measures
Exercise group | test | p-value | ||||
|---|---|---|---|---|---|---|
High adherence n = 86 | Low adherence n = 18 | |||||
No. | % | No. | % | |||
Disease duration (years) | ||||||
Mean± SD Median (range) | 6.57±3.5 6 (2–15) | 7.5±2.7 6 (4–14) | t=1.1 | 0.26 | ||
Comorbidities | ||||||
Yes (45) | 31 | 68.89 | 14 | 31.11 | 9 | 0.003* |
No (59) | 55 | 93.2 | 4 | 6.8 | ||
K-L grade: | ||||||
Two (53) | 42 | 79.25 | 11 | 20.75 | 0.88 | 0.64 |
Three (40) | 34 | 85 | 6 | 15 | ||
Four (11) | 10 | 90.91 | 1 | 9.09 | ||
VAS (baseline) | ||||||
Mean± SD Median(range) | 56.9±18.3 60 (20–90) | 64.2±11.2 60 (30–80) | MW=1.7 | 0.08 | ||
SF-36 (baseline) | ||||||
Mean± SD Median (range) | 61.1±7.5 63 (43–77) | 57.9±5.8 58 (45–71) | t=1.7 | 0.08 | ||
ESE A (baseline) | ||||||
Mean± SD Median(range) | 58.6±7.3 59.4 (37.7–74.4) | 56.3±4.6 56.6 (48.3–65) | t=1.3 | 0.19 | ||
VAS (6month) | ||||||
Mean± SD Median (range) | 38.7±13.4 40 (20–60) | 50.6±9.8 50 (30–70) | t=2.1 | 0.0004* | ||
SF-36 (6month) | ||||||
Mean± SD Median (range) | 74.1±9.7 73 (52–92) | 64.1±10.7 61 (50–86) | t=3.9 | ≤0.001* | ||
ESE A (6month) | ||||||
Mean± SD Median (range) | 72.8 ±9.8 73.2 (54.8–84.6) | 61.6 ±4.6 60 (55.9–68.3) | MW=5.8 | ≤0.001* | ||